HEADER IMMUNE SYSTEM 05-NOV-14 4RQS TITLE CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 TITLE 2 AND 17B FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2-DOMAIN CD4; COMPND 3 CHAIN: B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 17B FAB LIGHT CHAIN; COMPND 7 CHAIN: C; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: 17B FAB HEAVY CHAIN; COMPND 11 CHAIN: D; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: HIV-1 YU2 GP120 CORE CHIMERIC PROTEIN; COMPND 15 CHAIN: G; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 8 EXPRESSION_SYSTEM_TISSUE: OVARY; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 16 EXPRESSION_SYSTEM_TISSUE: KIDNEY; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 24 EXPRESSION_SYSTEM_TISSUE: KIDNEY; SOURCE 25 MOL_ID: 4; SOURCE 26 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (ISOLATE SOURCE 27 YU2); SOURCE 28 ORGANISM_COMMON: HIV-1; SOURCE 29 ORGANISM_TAXID: 362651; SOURCE 30 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 31 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 32 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 33 EXPRESSION_SYSTEM_TISSUE: KIDNEY KEYWDS IMMUNOGLOBULIN FOLD, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR L.KONG,I.A.WILSON,P.D.KWONG REVDAT 5 29-JUL-20 4RQS 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 28-JUN-17 4RQS 1 SOURCE REVDAT 3 25-FEB-15 4RQS 1 JRNL REVDAT 2 14-JAN-15 4RQS 1 JRNL REVDAT 1 31-DEC-14 4RQS 0 JRNL AUTH L.KONG,I.A.WILSON,P.D.KWONG JRNL TITL CRYSTAL STRUCTURE OF A FULLY GLYCOSYLATED HIV-1 GP120 CORE JRNL TITL 2 REVEALS A STABILIZING ROLE FOR THE GLYCAN AT ASN262. JRNL REF PROTEINS V. 83 590 2015 JRNL REFN ISSN 0887-3585 JRNL PMID 25546301 JRNL DOI 10.1002/PROT.24747 REMARK 2 REMARK 2 RESOLUTION. 4.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 13288 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.279 REMARK 3 R VALUE (WORKING SET) : 0.276 REMARK 3 FREE R VALUE : 0.322 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 666 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.5177 - 7.6740 0.91 2573 126 0.2784 0.3270 REMARK 3 2 7.6740 - 6.0951 0.95 2531 127 0.3026 0.3247 REMARK 3 3 6.0951 - 5.3258 0.96 2539 118 0.2263 0.2854 REMARK 3 4 5.3258 - 4.8394 0.97 2505 152 0.2492 0.3091 REMARK 3 5 4.8394 - 4.4928 0.96 2474 143 0.3007 0.3402 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 40.660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 7567 REMARK 3 ANGLE : 0.757 10284 REMARK 3 CHIRALITY : 0.052 1235 REMARK 3 PLANARITY : 0.003 1270 REMARK 3 DIHEDRAL : 21.440 2886 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RQS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-NOV-14. REMARK 100 THE DEPOSITION ID IS D_1000087681. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13317 REMARK 200 RESOLUTION RANGE HIGH (A) : 4.493 REMARK 200 RESOLUTION RANGE LOW (A) : 47.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 4.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.92000 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 77.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M SODIUM FORMATE, 16.6% PEG 3350, REMARK 280 0.1 M CACL2, 0.1 M ACETATE PH 4.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.92850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 85.65900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 85.65900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 113.89275 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 85.65900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 85.65900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 37.96425 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 85.65900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 85.65900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 113.89275 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 85.65900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 85.65900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 37.96425 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 75.92850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: 17B FAB (TWO CHAINS) AND 2-DOMAIN CD4 (ONE CHAIN) BOUND TO REMARK 300 HIV-1 GP120 (ONE CHAIN) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, D, G, A, E, F, H, I, J, REMARK 350 AND CHAINS: K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 44820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, G, A, E, F, H, I, J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 171.31800 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 -171.31800 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA B 182 REMARK 465 SER B 183 REMARK 465 ASN B 184 REMARK 465 THR B 185 REMARK 465 SER D 127 REMARK 465 SER D 128 REMARK 465 LYS D 129 REMARK 465 SER D 130 REMARK 465 THR D 131 REMARK 465 SER D 132 REMARK 465 GLY G 79 REMARK 465 ALA G 80 REMARK 465 ARG G 81 REMARK 465 SER G 82 REMARK 465 GLU G 83 REMARK 465 VAL G 84 REMARK 465 LYS G 85 REMARK 465 ARG G 405 REMARK 465 LYS G 406 REMARK 465 LEU G 407 REMARK 465 ASN G 408 REMARK 465 ASN G 409 REMARK 465 THR G 410 REMARK 465 GLY G 411 REMARK 465 ARG G 412 REMARK 465 LYS G 460 REMARK 465 ASP G 461 REMARK 465 GLU G 492 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN G 332 C2 NAG I 1 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY G 300 CA - C - N ANGL. DEV. = -15.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO B 48 49.18 -85.65 REMARK 500 LYS B 142 -68.10 -130.02 REMARK 500 GLN B 165 -15.84 73.95 REMARK 500 SER C 30 -131.94 61.32 REMARK 500 LEU C 47 -63.44 -107.40 REMARK 500 ALA C 51 -16.91 73.36 REMARK 500 ASN C 138 70.75 57.39 REMARK 500 ASN C 152 -4.73 67.79 REMARK 500 LYS C 169 -72.77 -103.51 REMARK 500 LYS C 190 -70.50 -107.45 REMARK 500 PHE D 146 138.51 -176.87 REMARK 500 THR D 160 -63.40 -122.71 REMARK 500 GLN G 258 -14.64 73.19 REMARK 500 GLU G 269 175.25 179.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY G 300 HIS G 330 137.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLY G 300 -19.41 REMARK 500 REMARK 500 REMARK: NULL DBREF 4RQS B 1 183 UNP P01730 CD4_HUMAN 26 208 DBREF 4RQS G 83 127 UNP P35961 ENV_HV1Y2 82 126 DBREF 4RQS G 195 297 UNP P35961 ENV_HV1Y2 191 293 DBREF 4RQS G 330 492 UNP P35961 ENV_HV1Y2 325 479 DBREF 4RQS D 1 214 PDB 4RQS 4RQS 1 214 DBREF 4RQS C 1 212 PDB 4RQS 4RQS 1 212 SEQADV 4RQS ASN B 184 UNP P01730 EXPRESSION TAG SEQADV 4RQS THR B 185 UNP P01730 EXPRESSION TAG SEQADV 4RQS GLY G 79 UNP P35961 EXPRESSION TAG SEQADV 4RQS ALA G 80 UNP P35961 EXPRESSION TAG SEQADV 4RQS ARG G 81 UNP P35961 EXPRESSION TAG SEQADV 4RQS SER G 82 UNP P35961 EXPRESSION TAG SEQADV 4RQS GLY G 128 UNP P35961 LINKER SEQADV 4RQS ALA G 129 UNP P35961 LINKER SEQADV 4RQS GLY G 194 UNP P35961 LINKER SEQADV 4RQS GLY G 298 UNP P35961 LINKER SEQADV 4RQS ALA G 299 UNP P35961 LINKER SEQADV 4RQS GLY G 300 UNP P35961 LINKER SEQRES 1 B 185 LYS LYS VAL VAL LEU GLY LYS LYS GLY ASP THR VAL GLU SEQRES 2 B 185 LEU THR CYS THR ALA SER GLN LYS LYS SER ILE GLN PHE SEQRES 3 B 185 HIS TRP LYS ASN SER ASN GLN ILE LYS ILE LEU GLY ASN SEQRES 4 B 185 GLN GLY SER PHE LEU THR LYS GLY PRO SER LYS LEU ASN SEQRES 5 B 185 ASP ARG ALA ASP SER ARG ARG SER LEU TRP ASP GLN GLY SEQRES 6 B 185 ASN PHE PRO LEU ILE ILE LYS ASN LEU LYS ILE GLU ASP SEQRES 7 B 185 SER ASP THR TYR ILE CYS GLU VAL GLU ASP GLN LYS GLU SEQRES 8 B 185 GLU VAL GLN LEU LEU VAL PHE GLY LEU THR ALA ASN SER SEQRES 9 B 185 ASP THR HIS LEU LEU GLN GLY GLN SER LEU THR LEU THR SEQRES 10 B 185 LEU GLU SER PRO PRO GLY SER SER PRO SER VAL GLN CYS SEQRES 11 B 185 ARG SER PRO ARG GLY LYS ASN ILE GLN GLY GLY LYS THR SEQRES 12 B 185 LEU SER VAL SER GLN LEU GLU LEU GLN ASP SER GLY THR SEQRES 13 B 185 TRP THR CYS THR VAL LEU GLN ASN GLN LYS LYS VAL GLU SEQRES 14 B 185 PHE LYS ILE ASP ILE VAL VAL LEU ALA PHE GLN LYS ALA SEQRES 15 B 185 SER ASN THR SEQRES 1 C 214 ASP ILE VAL MET THR GLN SER PRO ALA THR LEU SER VAL SEQRES 2 C 214 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 C 214 GLU SER VAL SER SER ASP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 C 214 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SER SEQRES 5 C 214 THR ARG ALA THR GLY VAL PRO ALA ARG PHE SER GLY SER SEQRES 6 C 214 GLY SER GLY ALA GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 C 214 GLN SER GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN TYR SEQRES 8 C 214 ASN ASN TRP PRO PRO ARG TYR THR PHE GLY GLN GLY THR SEQRES 9 C 214 ARG LEU GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL SEQRES 10 C 214 PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY SEQRES 11 C 214 THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO SEQRES 12 C 214 ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU SEQRES 13 C 214 GLN SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SEQRES 14 C 214 SER LYS ASP SER THR TYR SER LEU SER SER THR LEU THR SEQRES 15 C 214 LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA SEQRES 16 C 214 CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR SEQRES 17 C 214 LYS SER PHE ASN ARG GLY SEQRES 1 D 229 GLU VAL GLN LEU VAL GLU SER GLY ALA GLU VAL LYS LYS SEQRES 2 D 229 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 D 229 ASP THR PHE ILE ARG TYR SER PHE THR TRP VAL ARG GLN SEQRES 4 D 229 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY ARG ILE ILE SEQRES 5 D 229 THR ILE LEU ASP VAL ALA HIS TYR ALA PRO HIS LEU GLN SEQRES 6 D 229 GLY ARG VAL THR ILE THR ALA ASP LYS SER THR SER THR SEQRES 7 D 229 VAL TYR LEU GLU LEU ARG ASN LEU ARG SER ASP ASP THR SEQRES 8 D 229 ALA VAL TYR PHE CYS ALA GLY VAL TYR GLU GLY GLU ALA SEQRES 9 D 229 ASP GLU GLY GLU TYR ASP ASN ASN GLY PHE LEU LYS HIS SEQRES 10 D 229 TRP GLY GLN GLY THR LEU VAL THR VAL SER SER ALA SER SEQRES 11 D 229 THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER SEQRES 12 D 229 LYS SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU SEQRES 13 D 229 VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP SEQRES 14 D 229 ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO SEQRES 15 D 229 ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER SEQRES 16 D 229 VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR SEQRES 17 D 229 TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS SEQRES 18 D 229 VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 1 G 313 GLY ALA ARG SER GLU VAL LYS LEU GLU ASN VAL THR GLU SEQRES 2 G 313 ASN PHE ASN MET TRP LYS ASN ASN MET VAL GLU GLN MET SEQRES 3 G 313 HIS GLU ASP ILE ILE SER LEU TRP ASP GLN SER LEU LYS SEQRES 4 G 313 PRO CYS VAL LYS LEU THR PRO LEU CYS VAL GLY ALA GLY SEQRES 5 G 313 SER CYS ASN THR SER VAL ILE THR GLN ALA CYS PRO LYS SEQRES 6 G 313 VAL SER PHE GLU PRO ILE PRO ILE HIS TYR CYS ALA PRO SEQRES 7 G 313 ALA GLY PHE ALA ILE LEU LYS CYS ASN ASP LYS LYS PHE SEQRES 8 G 313 ASN GLY THR GLY PRO CYS THR ASN VAL SER THR VAL GLN SEQRES 9 G 313 CYS THR HIS GLY ILE ARG PRO VAL VAL SER THR GLN LEU SEQRES 10 G 313 LEU LEU ASN GLY SER LEU ALA GLU GLU GLU ILE VAL ILE SEQRES 11 G 313 ARG SER GLU ASN PHE THR ASN ASN ALA LYS THR ILE ILE SEQRES 12 G 313 VAL GLN LEU ASN GLU SER VAL VAL ILE ASN CYS THR GLY SEQRES 13 G 313 ALA GLY HIS CYS ASN LEU SER LYS THR GLN TRP GLU ASN SEQRES 14 G 313 THR LEU GLU GLN ILE ALA ILE LYS LEU LYS GLU GLN PHE SEQRES 15 G 313 GLY ASN ASN LYS THR ILE ILE PHE ASN PRO SER SER GLY SEQRES 16 G 313 GLY ASP PRO GLU ILE VAL THR HIS SER PHE ASN CYS GLY SEQRES 17 G 313 GLY GLU PHE PHE TYR CYS ASN SER THR GLN LEU PHE THR SEQRES 18 G 313 TRP ASN ASP THR ARG LYS LEU ASN ASN THR GLY ARG ASN SEQRES 19 G 313 ILE THR LEU PRO CYS ARG ILE LYS GLN ILE ILE ASN MET SEQRES 20 G 313 TRP GLN GLU VAL GLY LYS ALA MET TYR ALA PRO PRO ILE SEQRES 21 G 313 ARG GLY GLN ILE ARG CYS SER SER ASN ILE THR GLY LEU SEQRES 22 G 313 LEU LEU THR ARG ASP GLY GLY LYS ASP THR ASN GLY THR SEQRES 23 G 313 GLU ILE PHE ARG PRO GLY GLY GLY ASP MET ARG ASP ASN SEQRES 24 G 313 TRP ARG SER GLU LEU TYR LYS TYR LYS VAL VAL LYS ILE SEQRES 25 G 313 GLU MODRES 4RQS ASN G 295 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 386 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 448 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 276 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 289 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 234 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 262 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 241 ASN GLYCOSYLATION SITE MODRES 4RQS ASN G 332 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET BMA A 3 11 HET MAN A 4 11 HET MAN A 5 11 HET MAN A 6 11 HET MAN A 7 11 HET MAN A 8 11 HET MAN A 9 11 HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET NAG H 1 14 HET NAG H 2 14 HET NAG I 1 14 HET NAG I 2 14 HET NAG J 1 14 HET NAG J 2 14 HET NAG K 1 14 HET NAG K 2 14 HET BMA K 3 11 HET NAG L 1 14 HET NAG L 2 14 HET BMA L 3 11 HET NAG G 524 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE FORMUL 5 NAG 17(C8 H15 N O6) FORMUL 5 BMA 4(C6 H12 O6) FORMUL 5 MAN 6(C6 H12 O6) HELIX 1 1 ARG B 58 GLY B 65 5 8 HELIX 2 2 LYS B 75 SER B 79 5 5 HELIX 3 3 GLU B 150 SER B 154 5 5 HELIX 4 4 SER C 121 LYS C 126 1 6 HELIX 5 5 LYS C 183 GLU C 187 1 5 HELIX 6 6 ARG D 83 THR D 87 5 5 HELIX 7 7 SER D 156 ALA D 158 5 3 HELIX 8 8 SER D 187 LEU D 189 5 3 HELIX 9 9 ASN G 98 LEU G 116 1 19 HELIX 10 10 SER G 334 GLY G 354 1 21 HELIX 11 11 ASP G 368 THR G 373 1 6 HELIX 12 12 SER G 387 THR G 392 1 6 HELIX 13 13 ASP G 474 TYR G 484 1 11 SHEET 1 A 6 LYS B 2 LYS B 7 0 SHEET 2 A 6 GLN B 89 ALA B 102 1 O GLN B 94 N VAL B 4 SHEET 3 A 6 ASP B 80 VAL B 86 -1 N ASP B 80 O LEU B 95 SHEET 4 A 6 PHE B 26 LYS B 29 -1 N HIS B 27 O GLU B 85 SHEET 5 A 6 LYS B 35 GLN B 40 -1 O LEU B 37 N TRP B 28 SHEET 6 A 6 PHE B 43 LYS B 46 -1 O THR B 45 N GLY B 38 SHEET 1 B 4 LYS B 2 LYS B 7 0 SHEET 2 B 4 GLN B 89 ALA B 102 1 O GLN B 94 N VAL B 4 SHEET 3 B 4 LEU B 114 GLU B 119 -1 O THR B 117 N THR B 101 SHEET 4 B 4 LEU B 144 VAL B 146 -1 O LEU B 144 N LEU B 116 SHEET 1 C 3 VAL B 12 LEU B 14 0 SHEET 2 C 3 LEU B 69 ILE B 71 -1 O LEU B 69 N LEU B 14 SHEET 3 C 3 ALA B 55 ASP B 56 -1 N ASP B 56 O ILE B 70 SHEET 1 D 5 HIS B 107 LEU B 109 0 SHEET 2 D 5 LYS B 166 LEU B 177 1 O LEU B 177 N LEU B 108 SHEET 3 D 5 GLY B 155 GLN B 163 -1 N GLY B 155 O ILE B 174 SHEET 4 D 5 SER B 127 ARG B 131 -1 N SER B 127 O LEU B 162 SHEET 5 D 5 ASN B 137 GLY B 140 -1 O ILE B 138 N CYS B 130 SHEET 1 E 4 MET C 4 SER C 7 0 SHEET 2 E 4 ALA C 19 ALA C 25 -1 O ARG C 24 N THR C 5 SHEET 3 E 4 GLU C 70 ILE C 75 -1 O ILE C 75 N ALA C 19 SHEET 4 E 4 PHE C 62 SER C 67 -1 N SER C 63 O THR C 74 SHEET 1 F 6 THR C 10 VAL C 13 0 SHEET 2 F 6 THR C 102 ILE C 106 1 O GLU C 105 N LEU C 11 SHEET 3 F 6 VAL C 85 GLN C 90 -1 N TYR C 86 O THR C 102 SHEET 4 F 6 ALA C 34 GLN C 38 -1 N GLN C 38 O VAL C 85 SHEET 5 F 6 ARG C 45 TYR C 49 -1 O ARG C 45 N GLN C 37 SHEET 6 F 6 THR C 53 ARG C 54 -1 O THR C 53 N TYR C 49 SHEET 1 G 4 THR C 10 VAL C 13 0 SHEET 2 G 4 THR C 102 ILE C 106 1 O GLU C 105 N LEU C 11 SHEET 3 G 4 VAL C 85 GLN C 90 -1 N TYR C 86 O THR C 102 SHEET 4 G 4 THR C 97 PHE C 98 -1 O THR C 97 N GLN C 90 SHEET 1 H 4 SER C 114 PHE C 118 0 SHEET 2 H 4 THR C 129 PHE C 139 -1 O LEU C 135 N PHE C 116 SHEET 3 H 4 TYR C 173 SER C 182 -1 O LEU C 175 N LEU C 136 SHEET 4 H 4 SER C 159 VAL C 163 -1 N SER C 162 O SER C 176 SHEET 1 I 4 ALA C 153 GLN C 155 0 SHEET 2 I 4 LYS C 145 VAL C 150 -1 N TRP C 148 O GLN C 155 SHEET 3 I 4 VAL C 191 THR C 197 -1 O GLU C 195 N GLN C 147 SHEET 4 I 4 VAL C 205 ASN C 210 -1 O PHE C 209 N TYR C 192 SHEET 1 J 4 GLN D 3 GLU D 6 0 SHEET 2 J 4 VAL D 18 SER D 25 -1 O LYS D 23 N VAL D 5 SHEET 3 J 4 THR D 77 LEU D 82 -1 O LEU D 80 N VAL D 20 SHEET 4 J 4 VAL D 67 ASP D 72 -1 N ASP D 72 O THR D 77 SHEET 1 K 6 GLU D 10 LYS D 12 0 SHEET 2 K 6 THR D 107 VAL D 111 1 O LEU D 108 N GLU D 10 SHEET 3 K 6 ALA D 88 TYR D 96 -1 N TYR D 90 O THR D 107 SHEET 4 K 6 TYR D 32 GLN D 39 -1 N GLN D 39 O VAL D 89 SHEET 5 K 6 LEU D 45 ILE D 52 -1 O ILE D 51 N PHE D 34 SHEET 6 K 6 VAL D 56 TYR D 59 -1 O VAL D 56 N ILE D 52 SHEET 1 L 4 GLU D 10 LYS D 12 0 SHEET 2 L 4 THR D 107 VAL D 111 1 O LEU D 108 N GLU D 10 SHEET 3 L 4 ALA D 88 TYR D 96 -1 N TYR D 90 O THR D 107 SHEET 4 L 4 HIS D 102 TRP D 103 -1 O HIS D 102 N GLY D 94 SHEET 1 M 4 SER D 120 LEU D 124 0 SHEET 2 M 4 THR D 135 TYR D 145 -1 O LEU D 141 N PHE D 122 SHEET 3 M 4 TYR D 176 PRO D 185 -1 O LEU D 178 N VAL D 142 SHEET 4 M 4 VAL D 163 THR D 165 -1 N HIS D 164 O VAL D 181 SHEET 1 N 4 SER D 120 LEU D 124 0 SHEET 2 N 4 THR D 135 TYR D 145 -1 O LEU D 141 N PHE D 122 SHEET 3 N 4 TYR D 176 PRO D 185 -1 O LEU D 178 N VAL D 142 SHEET 4 N 4 VAL D 169 LEU D 170 -1 N VAL D 169 O SER D 177 SHEET 1 O 3 THR D 151 TRP D 154 0 SHEET 2 O 3 TYR D 194 HIS D 200 -1 O ASN D 197 N SER D 153 SHEET 3 O 3 THR D 205 VAL D 211 -1 O VAL D 211 N TYR D 194 SHEET 1 P 2 GLU G 91 ASN G 94 0 SHEET 2 P 2 THR G 236 CYS G 239 -1 O GLY G 237 N PHE G 93 SHEET 1 Q 4 CYS G 196 THR G 202 0 SHEET 2 Q 4 VAL G 120 CYS G 126 -1 N THR G 123 O SER G 199 SHEET 3 Q 4 LYS G 432 MET G 434 -1 O LYS G 432 N LEU G 122 SHEET 4 Q 4 ILE G 423 ASN G 425 -1 N ILE G 424 O ALA G 433 SHEET 1 R 3 VAL G 242 VAL G 245 0 SHEET 2 R 3 PHE G 223 CYS G 228 -1 N LYS G 227 O SER G 243 SHEET 3 R 3 TYR G 486 LYS G 490 -1 O LYS G 487 N LEU G 226 SHEET 1 S 4 LEU G 259 LEU G 261 0 SHEET 2 S 4 CYS G 445 ARG G 456 -1 O GLY G 451 N LEU G 260 SHEET 3 S 4 THR G 465 PRO G 470 -1 O ARG G 469 N THR G 455 SHEET 4 S 4 THR G 358 PHE G 361 1 N ILE G 360 O GLU G 466 SHEET 1 T 8 VAL G 271 ARG G 273 0 SHEET 2 T 8 ILE G 284 GLN G 287 -1 O ILE G 285 N ARG G 273 SHEET 3 T 8 CYS G 445 ARG G 456 -1 O LEU G 454 N ILE G 284 SHEET 4 T 8 VAL G 292 THR G 297 -1 N CYS G 296 O CYS G 445 SHEET 5 T 8 HIS G 330 LEU G 333 -1 O HIS G 330 N THR G 297 SHEET 6 T 8 ILE G 414 ILE G 420 -1 O LEU G 416 N CYS G 331 SHEET 7 T 8 GLU G 381 CYS G 385 -1 N TYR G 384 O ARG G 419 SHEET 8 T 8 HIS G 374 CYS G 378 -1 N PHE G 376 O PHE G 383 SSBOND 1 CYS B 16 CYS B 84 1555 1555 2.03 SSBOND 2 CYS B 130 CYS B 159 1555 1555 2.03 SSBOND 3 CYS C 23 CYS C 88 1555 1555 2.03 SSBOND 4 CYS C 134 CYS C 194 1555 1555 2.03 SSBOND 5 CYS D 22 CYS D 92 1555 1555 2.03 SSBOND 6 CYS D 140 CYS D 196 1555 1555 2.03 SSBOND 7 CYS G 119 CYS G 205 1555 1555 2.03 SSBOND 8 CYS G 126 CYS G 196 1555 1555 2.03 SSBOND 9 CYS G 218 CYS G 247 1555 1555 2.03 SSBOND 10 CYS G 296 CYS G 331 1555 1555 2.03 SSBOND 11 CYS G 378 CYS G 445 1555 1555 2.03 SSBOND 12 CYS G 385 CYS G 418 1555 1555 2.03 LINK ND2 ASN G 234 C1 NAG K 1 1555 1555 1.44 LINK ND2 ASN G 241 C1 NAG F 1 1555 1555 1.44 LINK ND2 ASN G 262 C1 NAG A 1 1555 1555 1.44 LINK ND2 ASN G 276 C1 NAG L 1 1555 1555 1.44 LINK ND2 ASN G 289 C1 NAG H 1 1555 1555 1.44 LINK ND2 ASN G 295 C1 NAG G 524 1555 1555 1.44 LINK ND2 ASN G 332 C1 NAG I 1 1555 1555 1.44 LINK ND2 ASN G 386 C1 NAG E 1 1555 1555 1.44 LINK ND2 ASN G 448 C1 NAG J 1 1555 1555 1.44 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.44 LINK O4 NAG A 2 C1 BMA A 3 1555 1555 1.44 LINK O3 BMA A 3 C1 MAN A 4 1555 1555 1.44 LINK O6 BMA A 3 C1 MAN A 7 1555 1555 1.44 LINK O2 MAN A 4 C1 MAN A 5 1555 1555 1.44 LINK O2 MAN A 5 C1 MAN A 6 1555 1555 1.44 LINK O3 MAN A 7 C1 MAN A 8 1555 1555 1.38 LINK O6 MAN A 7 C1 MAN A 9 1555 1555 1.66 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.45 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.44 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.44 LINK O4 NAG I 1 C1 NAG I 2 1555 1555 1.44 LINK O4 NAG J 1 C1 NAG J 2 1555 1555 1.44 LINK O4 NAG K 1 C1 NAG K 2 1555 1555 1.44 LINK O4 NAG K 2 C1 BMA K 3 1555 1555 1.44 LINK O4 NAG L 1 C1 NAG L 2 1555 1555 1.44 LINK O4 NAG L 2 C1 BMA L 3 1555 1555 1.44 CISPEP 1 SER C 7 PRO C 8 0 -3.01 CISPEP 2 TRP C 94 PRO C 95 0 -2.95 CISPEP 3 TYR C 140 PRO C 141 0 1.53 CISPEP 4 PHE D 146 PRO D 147 0 -6.86 CISPEP 5 GLU D 148 PRO D 149 0 -6.72 CISPEP 6 THR G 462 ASN G 463 0 -1.76 CRYST1 171.318 171.318 151.857 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005837 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005837 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006585 0.00000